Volume 12 Issue 10
Sep.  2021
Turn off MathJax
Article Contents
Xingdong Zhou, Hui Wang, Qun Ji, Mingjuan Du, Yuexia Liang, Huanhuan Li, Fan Li, Hang Shang, Xiujuan Zhu, Wei Wang, Lichun Jiang, Alexey V. Stepanov, Tianyu Ma, Nanxin Gong, Xiaodong Jia, Alexander G. Gabibov, Zhiyong Lou, Yinying Lu, Yu Guo, Hongkai Zhang, Xiaoming Yang. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine[J]. Protein&Cell, 2021, 12(10): 818-823. doi: 10.1007/s13238-021-00840-z
Citation: Xingdong Zhou, Hui Wang, Qun Ji, Mingjuan Du, Yuexia Liang, Huanhuan Li, Fan Li, Hang Shang, Xiujuan Zhu, Wei Wang, Lichun Jiang, Alexey V. Stepanov, Tianyu Ma, Nanxin Gong, Xiaodong Jia, Alexander G. Gabibov, Zhiyong Lou, Yinying Lu, Yu Guo, Hongkai Zhang, Xiaoming Yang. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine[J]. Protein&Cell, 2021, 12(10): 818-823. doi: 10.1007/s13238-021-00840-z

Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine

doi: 10.1007/s13238-021-00840-z
Funds:

This work was supported by the National Key Research and Development Plan of China (grant numbers: 2018YFE0200400 and 2017YFA0504801), the Fundamental Research Funds for the Central Universities, Nankai University (grant numbers ZB19100123, 63191212 and 63191316), ShanghaiTech University Shanghai Institute for Advanced Immunochemical Studies (SIAIS) research funding and Russian Scientific Foundation (grant number 17-74-30019). The authors declare no competing interests.

  • Publish Date: 2021-09-27
  • loading
  • [1]
    Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ et al (2020) Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 383:2427-2438
    [2]
    Brouwer PJM, Caniels TG, van der Straten K, Snitselaar JL, Aldon Y, Bangaru S, Torres JL, Okba NMA, Claireaux M, Kerster G et al(2020) Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science 369:643-650
    [3]
    Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C et al (2020) Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput Single-cell sequencing of convalescent patients' B cells. Cell 182:73-84
    [4]
    Jones I, Roy P (2021) Sputnik V COVID-19 vaccine candidate appears safe and effective. Lancet. 397(10275):642-643
    [5]
    Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, Yu J, Shan S, Zhou B, Song S et al (2020) Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584:115-119
    [6]
    Lerner RA (2006) Manufacturing immunity to disease in a test tube:the magic bullet realized. Angew Chem 45:8106-8125
    [7]
    Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603-2615
    [8]
    Rajan S, Kierny MR, Mercer A, Wu J, Tovchigrechko A, Wu H, Dall Acqua WF, Xiao X, Chowdhury PS (2018) Recombinant human B cell repertoires enable screening for rare, specific, and natively paired antibodies. Commun Biol 1:5
    [9]
    von Boehmer L, Liu C, Ackerman S, Gitlin AD, Wang Q, Gazumyan A, Nussenzweig MC (2016) Sequencing and cloning of antigenspecific antibodies from mouse memory B cells. Nat Protoc 11:1908-1923
    [10]
    Wang B, DeKosky BJ, Timm MR, Lee J, Normandin E, Misasi J, Kong R, McDaniel JR, Delidakis G, Leigh KE et al (2018) Functional interrogation and mining of natively paired human V (H):V(L) antibody repertoires. Nat Biotechnol 36:152-155
    [11]
    Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, Xu W, Zhao Y, Li N, Zhang J et al (2020) Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell 182:713-721.e719
    [12]
    Wang P, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS et al (2021) Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization. bioRxiv, 2021.2001.2025.428137.
    [13]
    Wen GP, He L, Tang ZM, Wang SL, Zhang X, Chen YZ, Lin X, Liu C, Chen JX, Ying D et al (2020) Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans. Nat Commun 11:3971
    [14]
    Wu S, Zhong G, Zhang J, Shuai L, Zhang Z, Wen Z, Wang B, Zhao Z, Song X, Chen Y et al (2020) A single dose of an adenovirusvectored vaccine provides protection against SARS-CoV-2 challenge. Nat Commun 11:4081
    [15]
    Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z et al (2021) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV:a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis 21:39-51
  • PAC-0818-21082-ZHK_supple.pdf
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (193) PDF downloads(45) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return